Bioactivity:

1. Vitexicarpin can significantly reduce vascular inflammation, through inhibition of ROS-NF-_B pathway in vascular endothelial cells. 2. Vitexicarpin may become a potential leading drug in the therapy of prostate carcinoma.

CAS nr:

479-91-4

Purity:

98%

Molecular Weight:

374,34

SMILES:

COC1=C(C=C(C=C1)C2=C(C(=O)C3=C(C(=C(C=C3O2)OC)OC)O)OC)O

Formula:

C19H18O8

Pathway:

Stem Cells,JAK/STAT signaling

Target:

STAT,STAT